# The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia

> **NCT01010256** · — · TERMINATED · sponsor: **University of Arkansas** · enrollment: 4 (actual)

## Conditions studied

- Chronic Myelomonocytic Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01010256
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11-01
- **Primary completion:** 2019-10-03
- **Final completion:** 2019-10-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** PI moved institutions
- **Last updated:** 2020-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010256, "The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01010256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*